Trial intelligence / Profile preview

MenACYW Conjugate Vaccine in Healthy Children and Adolescents in China

NCT07135986Phase 3Completed

Sponsor
Sanofi
Start
Sep 2025
Primary completion
May 2026
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Meningococcal ACWY conjugate vaccine in meningococcal infection, sponsored by Sanofi. Started Sep 2025; status: completed.

02

Drugs

Meningococcal ACWY conjugate vaccine
03

Conditions

meningococcal infection

Beyond the preview

Go deeper on NCT07135986.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07135986.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call